OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation.
Publication
, Journal Article
Knechtle, SJ; Pirsch, JD; Groshek, M; Reed, A; D'Alessandro, AM; Kalayoglu, M; Belzer, FO; Sollinger, HW
Published in: Transplant Proc
February 1991
Duke Scholars
Published In
Transplant Proc
ISSN
0041-1345
Publication Date
February 1991
Volume
23
Issue
1 Pt 2
Start / End Page
1581 / 1582
Location
United States
Related Subject Headings
- Retrospective Studies
- Receptors, Antigen, T-Cell
- Pancreas Transplantation
- Opportunistic Infections
- Muromonab-CD3
- Kidney Transplantation
- Immunosuppression Therapy
- Humans
- Graft Survival
- Graft Rejection
Citation
APA
Chicago
ICMJE
MLA
NLM
Knechtle, S. J., Pirsch, J. D., Groshek, M., Reed, A., D’Alessandro, A. M., Kalayoglu, M., … Sollinger, H. W. (1991). OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation. Transplant Proc, 23(1 Pt 2), 1581–1582.
Knechtle, S. J., J. D. Pirsch, M. Groshek, A. Reed, A. M. D’Alessandro, M. Kalayoglu, F. O. Belzer, and H. W. Sollinger. “OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation.” Transplant Proc 23, no. 1 Pt 2 (February 1991): 1581–82.
Knechtle SJ, Pirsch JD, Groshek M, Reed A, D’Alessandro AM, Kalayoglu M, et al. OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation. Transplant Proc. 1991 Feb;23(1 Pt 2):1581–2.
Knechtle, S. J., et al. “OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation.” Transplant Proc, vol. 23, no. 1 Pt 2, Feb. 1991, pp. 1581–82.
Knechtle SJ, Pirsch JD, Groshek M, Reed A, D’Alessandro AM, Kalayoglu M, Belzer FO, Sollinger HW. OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation. Transplant Proc. 1991 Feb;23(1 Pt 2):1581–1582.
Published In
Transplant Proc
ISSN
0041-1345
Publication Date
February 1991
Volume
23
Issue
1 Pt 2
Start / End Page
1581 / 1582
Location
United States
Related Subject Headings
- Retrospective Studies
- Receptors, Antigen, T-Cell
- Pancreas Transplantation
- Opportunistic Infections
- Muromonab-CD3
- Kidney Transplantation
- Immunosuppression Therapy
- Humans
- Graft Survival
- Graft Rejection